Wolters Kluwer

Preferences

   Bookmark
Current Time Inside Cache Tag Helper: 9/30/2020 4:06:34 PM and Model.VendorId = 62443

Wolters Kluwer's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

Emmi
COVID-19 overview video, phone outreach, and discharge instructions

Free Video Content

Through Emmi, Wolters Kluwer is helping people globally understand what COVID-19 is and what preventative measures they can take. They have released and are continuously updating “Understanding COVID-19 and How to Stay Safe.” This video helps educate the public on ways to stay healthy during this pandemic by explaining:

  • What COVID-19 is and how it's spread
  • What the symptoms are for COVID-19
  • What to do if you are feeling sick
  • What to do if you are worried you’ve been exposed
  • How to stay healthy
  • How to slow the spread of the virus

Available in 18 languages, this PSA is free and available for anyone seeking to educate the public and their communities. It can be embedded in websites, social media, and email campaigns. For Epic customers, it is available in the COVID-19 patient-facing task in MyChart and through the Self Triage workflow in the Foundation.

Phone Outreach

In addition, with EmmiPrevent for COVID-19, Wolters Kluwer is helping providers keep their patients safe by automating communication with large numbers of them more consistently. This outbound IVR solution helps educate patients and communities (especially high-risk patient populations) and reduces the strain on already over-burdened frontline healthcare workers during this unprecedented time.

Wolters Kluwer is providing this service for free (waived fees for set-up, deployment, and an “inventory” of calls) for any US-based healthcare provider organization. This solution will be available for the remainder of 2020.

Discharge Instructions from Emmi

Our updated discharge instructions are now available, including easy-to-read information about recommended care at home, followup care, drugs, what physical activity will be limited, and more.

Health Language Reference Data Management
COVID-19 related standard codes and terminology updates

In partnership with CMS, AMA, and SNOMED International, Wolters Kluwer has accelerated updates to their Reference Data Management solution in order to provide clients a single source for the most up to date diagnosis, problem, and procedure codes, including the recently announced COVID-19 SNOMED CT and ICD-10 reference codes, enabling clients to accurately code, analyze, and report coronavirus cases.

Sentri7
Clinical surveillance resources for COVID-19

As healthcare organizations prepare for the expected surge in COVID-19 cases and strain on resources, maintaining a state of proactive readiness will be paramount. Sentri7 clinical surveillance integrates into existing EHR infrastructures to continuously monitor patient conditions and deliver actionable, intelligent, and measurable alerts directly into clinician workflows. By breaking down data silos that exist across healthcare settings, Sentri7 automates surveillance of medication and culture data to ensure clinicians are armed with evidence-based guidance in real-time to stay in step with outbreaks, speed response, and make the best patient decisions. Notably, the solution has a proven track record of reducing hospital-acquired infections (HAIs) and isolation management compliance.

Features immediately available to all Sentri7 customers include:

  • Adopt evidence-based COVID-19 Rule Content in minutes to seamlessly monitor hospitalized patients who have tested positive for the condition. Real-time alerts are triggered if qualifying patients are flagged in the EHR or transmitted back to the EHR from an outside lab.
  • Positive COVID-19 lab results populate Sentri7’s Notifiable Conditions. Confirmed coronavirus cases are presented in a centralized view to improve monitoring of positive cases and to streamline reporting to hospital leaders and public agencies.
  • The COVID-19 Monitoring Analytics Dashboard for Sentri7 provides a comprehensive, interactive view of cases and related testing for hospital or health system, including but not limited to: total patients tested versus positive cases; patients in critical care; average length of stay among COVID-19 cases; age distribution of COVID-19 patients; and breakdown of community-acquired versus healthcare-acquired infections.

While there is currently no FDA-approved antiviral treatment available for COVID-19, inevitably some patients will develop secondary bacterial infections and will require antimicrobial therapies. Antimicrobial stewardship remains an industry priority amid alarming statistics related to antimicrobial resistance. In addition, a surge of patients in hospitals across the world has led to drug shortages, making the prudent use of antimicrobials for the shortest duration possible a key strategy to conserve pharmaceutical supply.

  • Sentri7 helps hospitals and health systems improve appropriate use of antibiotics, while arming clinicians with information to minimize drug costs, prevent harm, or avoid the potential for adverse events.
  • Care teams can leverage the power of Sentri7’s high-impact alerts to guide proper therapy, flag antimicrobial misuse, and identify opportunities to contain drug costs and conserve use by proactively flagging drug substitutes.

Additionally, advanced analytics and ready-made reports deliver unprecedented visibility into the measurable impact of interventions in terms of cost and outcomes performance. Hospitals and health systems of all sizes depend on Sentri7 to optimize medication therapy as well as reduce readmissions, HAIs, and length of stay.

Sentri7
Insights and recommendations to optimize drug therapies, enhance antimicrobial stewardship programs, and manage medication use

Sentri7 clinical surveillance empowers pharmacists with patient-specific insights and recommendations to optimize drug therapies, enhance antimicrobial stewardship programs, and manage medication use to ensure patient safety and reduce costs.

While there is no FDA-approved antiviral treatment available for COVID-19, effectively managing and monitoring current inventory for key medications is necessary, and pharmacy teams can use Sentri7 out-of-the-box rule content to monitor key drugs, medication duration review, and opportunities for de-escalation.

Features immediately available to all Sentri7 customers include:

  • Adopt evidence-based COVID-19 Rule Content in minutes to seamlessly monitor key drugs being used to treat COVID-19 patients. Evidence-based clinical content can be adopted to identify and monitor patients who are receiving off-label or investigational drugs of interest (e.g. remdesivir, hydroxychloroquine).
  • Intuitive, dynamic dashboards and reporting for a real-time view of your clinical initiatives including rule performance. On-demand access to key reports on your COVID-19 initiative, providing granular detail into intervention patterns, trends and key metrics by prescriber, facility, and system-level.
    • COVID-19 Monitoring Dashboard provides key metrics on number of tests conducted and results, mean length of hospitalization, ICU admission, and other metrics to assist pharmacists in forecasting drug utilization and resource allocation.
  • Updated content to facilitate drug shortage management providing real-time alerts to identify patients on drugs with limited supply to facilitate conversion to second line drugs or early discontinuation when clinically appropriate.

Inevitably some patients will develop secondary bacterial infections and will require antimicrobial therapies. Antimicrobial stewardship remains an industry priority amid alarming statistics related to antimicrobial resistance.

  • Sentri7 helps hospitals and health systems improve appropriate use of antibiotics, while arming clinicians with information to minimize drug costs, prevent harm, or avoid the potential for adverse events.
  • Care teams can leverage the power of Sentri7’s high-impact alerts to guide proper therapy, flag antimicrobial misuse, and identify opportunities to contain drug costs by proactively flagging drug substitutes.

Additionally, advanced analytics and ready-made reports deliver unprecedented visibility into the measurable impact of interventions in terms of cost and outcomes performance. Hospitals and health systems of all sizes depend on Sentri7 to optimize medication therapy as well as reduce readmissions, HAIs and length of stay.

UpToDate
Recommendations and reference material on the treatment of COVID-19

For clinicians at the front lines of the outbreak who are seeking the most current, evidence-based clinical decision support, the following topics on UpToDate are freely available to all:

  • COVID-19
    • Clinical topic
    • Patient education topics
    • Society guidelines
  • Pulmonary and Critical Care Medicine
    • Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults
    • Acute respiratory distress syndrome: Supportive care and oxygenation in adults
    • Acute respiratory distress syndrome: Epidemiology, pathophysiology, pathology, and etiology in adults
    • Ventilator management strategies for adults with acute respiratory distress syndrome
    • Prone ventilation for adult patients with acute respiratory distress syndrome
    • Extracorporeal membrane oxygenation (ECMO) in adults
    • Patient education: Acute respiratory distress syndrome (The Basics)
  • Guest Pass Program
    • In addition, Wolters Kluwer is making individual guest passes to UpToDate available to clinicians working and supporting those on the front lines. These are for clinicians who do not already have access to UpToDate through institutional or individual subscriptions.
    • Also, please visit http://healthclarity.wolterskluwer.com/coronavirus-resources.html for all Wolters Kluwer COVID-19 resources, which are continually updated and expanded. Resources are subject to change without notice.

Lippincott nursing resources
Rapid development of curricula to support individual educational paths around COVID-19

Amid fluid and rapidly evolving guidance related to COVID-19, clinician access to the latest evidence is critical—especially as global healthcare systems prepare for increased demand for services and a strain on resources. The Lippincott product suite is uniquely positioned to get nurses and other allied clinicians up to speed quickly to blend the art and science of care delivery in support of optimal patient outcomes.

Supporting unexpected coverage and rapid deployment needs: Lippincott Learning enables rapid development of curricula to support individual educational paths around COVID-19, enhancing existing clinical and management skills as well as developing new skill areas to accommodate the need to “float” or cover needs in multiple specialties. In addition, Lippincott Blended Learning supports the rapid deployment of “need to know” information, quickly moving nurses and other clinicians from training to productivity as the need for services continues to increase.

Additionally, Lippincott Procedures and Lippincott Advisor provide the immediate point-of-care guidance needed to eliminate care variability, increase workflow efficiencies and drive improved outcomes in any care setting. Lippincott Procedures provides instant, online access to evidence-based procedure guidance across more than 1,700 procedures and skills from a wide variety of nursing specialties, enabling clinical staff to standardize care around industry best practices. Lippincott Advisor provides immediate, evidencebased, online nursing clinical-decision support at the point of care via more than 17,000 monographs and patient teaching handouts. Armed with access to the latest COVID-19 guidance, hospitals and health systems can ensure that staff and patients follow proper protocols to ensure safety for all stakeholders.

Lippincott also provides a comprehensive COVID-19 resource page that is updated on a regular basis.

Health Language Clinical Interface Terminology
COVID-19 related code and terminology updates for accurate clinician search and documentation

Wolters Kluwer has accelerated updates to their Clinical Interface Terminology solution to incorporate new search synonyms, SNOMED CT, and ICD-10 codes related to COVID-19. Through their EHR vendor partners, these updates support 300,000+ clinicians to accurately and efficiently document COVID-19 related diagnoses, problems, and procedures at the point-of-care.


Current Time Inside Cache Tag Helper: 9/30/2020 4:06:34 PM and Model.VendorId = 62443

Best in KLAS Awards


Current Time Inside Cache Tag Helper: 9/30/2020 4:06:34 PM and Model.VendorId = 62443

Software Overall Score Data collected between Sep 2019 - Sep 2020

##.#

 Product
Segment